NYSE:MDC - M.D.C. Stock Price, Forecast & News

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C. declared a quarterly dividend on Wednesday, January 29th. Investors of record on Wednesday, February 12th will be paid a dividend of $0.33 per share on Wednesday, February 26th. This represents a $1.32 annualized dividend and a yield of 2.88%. The ex-dividend date of this dividend is Tuesday, February 11th. This is an increase from M.D.C.'s previous quarterly dividend of $0.30. View M.D.C.'s Dividend History.

M.D.C. Holdings, Inc. (NYSE:MDC) announced its quarterly earnings results on Thursday, January, 30th. The construction company reported $1.42 EPS for the quarter, beating the Zacks' consensus estimate of $1.27 by $0.15. The construction company earned $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. M.D.C. had a net margin of 7.24% and a return on equity of 14.11%. The company's revenue was up 25.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.95 earnings per share. View M.D.C.'s Earnings History.

M.D.C. is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for M.D.C..

6 analysts have issued 12-month price objectives for M.D.C.'s stock. Their forecasts range from $41.00 to $49.00. On average, they anticipate M.D.C.'s share price to reach $44.00 in the next twelve months. This suggests that the stock has a possible downside of 4.0%. View Analyst Price Targets for M.D.C..

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for M.D.C..

Media headlines about MDC stock have trended somewhat negative on Sunday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. M.D.C. earned a coverage optimism score of -1.8 on InfoTrie's scale. They also gave headlines about the construction company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for M.D.C..

M.D.C. saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 1,700,000 shares, an increase of 6.9% from the January 15th total of 1,590,000 shares. Based on an average daily volume of 569,800 shares, the days-to-cover ratio is currently 3.0 days. Currently, 3.4% of the company's stock are short sold. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include D. R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), TRI Pointe Group (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV).

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include NVIDIA (NVDA), Alibaba Group (BABA), Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Bank of Hawaii (BOH), Arch Capital Group (ACGL), Intel (INTC), Netflix (NFLX) and Xilinx (XLNX).

M.D.C.'s stock is owned by a number of of institutional and retail investors. Top institutional shareholders include CVentures Inc. (12.91%), LSV Asset Management (3.12%), State Street Corp (2.89%), Bank of New York Mellon Corp (2.17%), Hamlin Capital Management LLC (2.17%) and FMR LLC (1.64%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including Hamlin Capital Management LLC, Bank of New York Mellon Corp, Marshall Wace North America L.P., Marshall Wace LLP, Royce & Associates LP, Goldman Sachs Group Inc., Driehaus Capital Management LLC and Brandes Investment Partners LP. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

MDC stock was purchased by a variety of institutional investors in the last quarter, including CVentures Inc., Vaughan Nelson Investment Management L.P., William Blair Investment Management LLC, Jupiter Asset Management Ltd., UBS Group AG, Peregrine Capital Management LLC, Barclays PLC and Heartland Advisors Inc.. View Insider Buying and Selling for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $45.83.

M.D.C. has a market capitalization of $2.87 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis. M.D.C. employs 1,656 workers across the globe.View Additional Information About M.D.C..

The official website for M.D.C. is http://www.mdcholdings.com/.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]